Twist Biopharma is at the forefront of antibody discovery and optimization. Using our proprietary synthetic DNA libraries and AI-powered platform, we're revolutionizing the way therapeutic antibodies are developed. Our cutting-edge approach allows for rapid identification and engineering of antibodies with superior binding affinity, specificity, and developability profiles. By combining the power of synthetic biology with machine learning, Twist Biopharma is accelerating the path from target to clinic, potentially saving years in traditional antibody discovery timelines. Our partnerships with leading pharmaceutical companies have already yielded promising candidates for treating cancer, autoimmune disorders, and infectious diseases. At Twist Biopharma, we're not just discovering antibodies; we're reshaping the future of medicine.
.png){kind=small}
